medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2013, Number 2

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2013; 29 (2)

Hemovigilance of adverse reactions to blood donation

Silva BHM, Bencomo HAA, López FR, Benet RM, Ballester SJM

Language: Spanish
References: 20
Page:
PDF size: 113.71 Kb.


ABSTRACT

Introduction: from January 2003 to December 2011 a program of hemovigilance was developed to increase the safety of transfusion in the province of Matanzas.
Objective: to analyze the effects of this program on the adverse reactions of blood donors.
Methods: adverse reactions to blood donation were identified in 2002 prior to the introduction of the program. The donation service was improved with the revision of procedures and standard practice; epidemiological and geographic data was included in the donor's selection process. From 2003 on, the adverse reactions to donations were notified using a form specially designed; causes were analyzed and prevention and corrective actions were taken. Other proceedings were applied to prevent negative reactions at donation and to improve the quality of blood collection, such as training and advice to donors. A quick alert system was set up to detect and to correct the risks related to donation and the quality of the collection.
Results: there was a decrease on the donor's reaction rate from 10, 1 out of 1 000 donations in 2002 to 1,4 out of 1000 in 2011. Severe adverse reactions were eliminated and moderate reactions were minimized. The most frequent was the vasovagal reaction.
Conclusions: Hemovigilance is an effective tool to increase donors' safety and to improve the quality of blood collection and it can be implemented with scarce resources.


REFERENCES

  1. Jorgensen J, Sorensen BS. Donor vigilance. ISBT Sci Ser. 2008 Jun; (3):48-53.

  2. Benjamin RJ. Donor hemovigilance: safety as the first priority of blood donor management. ISBT Sci Ser. 2010 Jul; (5): 20611.

  3. Ayob Y. Hemovigilance in developing countries. Biologicals. 2010 Jan; 38 (1): 91-6.

  4. Faber JC. Review of main haemovigilance systems in the world. Transfus Clin Biol. 2009 May; 16 (2):86-92.

  5. de Vries RRP, Faber JC, Strengers PF. Hemovigilance an effective tool for improving transfusion practice. Vox Sang. 2011Jan; 100 (1):60-7.

  6. Eder A, Goldman M, Rossmann S, Waxman D, Bianco C. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (haemovigilance). Transfus Med Rev. 2009 Jul; 23 (3):205-20.

  7. Okazaki H. The benefits of the Japanese haemovigilance system for better patient care. ISBT Sci Ser. 2007 Nov; 2(2):104-9.

  8. Nakajima K. Donor complications and donor care. ISBT Sci Ser. 2009 Nov; 4 (2): 4117.

  9. Working Group on Complications Related to Blood Donation JF (2008). Standard for Surveillance of Complications Related to Blood D Donation». 2008.European Haemovigilance Network: 11[citado 12 Dic 2009];. Disponible en:. http://www.isbtweb. org/members_only/files/society/StandardSurveillanceDOCO.pdf .

  10. Offergeld R, Hamouda O, Burger R. Epidemiological data an important part of the hemovigilance system. Transfus Med Hemother. 2010 Jun; 37 (3):12530.

  11. Crocco A, D'Elia D. Adverse reactions during voluntary donation if blood and or blood components. A statisticalepidemiological study. Blood Transfus. 2007 Jul; 5(3):143-52.

  12. Kamel H, Tomasulo P, Bravo M, Wiltbankk T, Cusik R, James RC, et al. Delayed adverse reaction to blood donation. Transfusion. 2010 Mar; 50(3):556-65.

  13. Garozzo G, Crocco I, Giussani B, Martinucci A, Monacelly S, Randi V. Adverse reactions to blood donation: the READ projet. Blood Transfus. 2010 Jan; 8(1):49-62.

  14. Rebibo D, Danic B. Haemovigilance donors: methods and results. Transfus Clin Biol. 2007 May; 14 (1):142-6.

  15. Sorensen BS, Johnsen SP, Jorgensen J. Complications related to blood donation: population based study. Vox Sang. 2008 Feb; 94(2):132-7.

  16. Eder AF, Dy BA, Kennedy JM, Notari IEP, Strupp A, Wessel ME, et al. The american red cross donor hemovigilance program: complications of the blood donation reported in 2006. Transfusion. 2008 Sep; 48(9): 1809-19.

  17. Damanhouri GA. The impact of training in transfusion medicine. ISBT Sci Ser. 2009 Mar; 4(1):95-8.

  18. Gongalvez TT, Sabino E, Alves Salles N, de Almeida Neto C, Mendrone jr A, Dorlhiac PE, et al. The impact of simple donor education on donor behavioral deferral and infectious disease rates in SãoPaulo, Brazil. Transfusion.2010 Apr; 50(4):909-17.

  19. Rios J, Koch T. How do I tell a blood donor that her or she was positive VIH test? Transfusion. 2009 Oct; 49 (10):2024-32.

  20. Teo D, Dhingra N. Editorial: blood transfusion in countries with limited resources. Transfus Altern Transfus Med. 2008 Jun;10 (2):51-2.




2020     |     www.medigraphic.com